clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT03337100 |
P17 | country | United States of America | Q30 |
P582 | end time | 2020-04-30 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 6 | |
P4844 | research intervention | naloxone | Q282902 |
P6153 | research site | Denver Health Medical Center | Q3023367 |
P580 | start time | 2017-11-27 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy |